Stay updated on Upadacitinib in RA: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib in RA: Safety & Efficacy Clinical Trial page.

Latest updates to the Upadacitinib in RA: Safety & Efficacy Clinical Trial page
- Check2 days agoChange DetectedRemoved 'Rheumatoid arthritis' and related topics, including MedlinePlus Genetics, from the page's related topics/keywords. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check9 days agoChange DetectedThe page now displays Revision: v3.3.4, replacing the previous Revision: v3.3.3. This appears to be an administrative update to the documentation.SummaryDifference0.0%

- Check17 days agoChange DetectedAdded related topics: 'Rheumatoid arthritis' and 'MedlinePlus Genetics' to the page.SummaryDifference0.1%

- Check24 days agoChange DetectedRemoved the 'Rheumatoid arthritis' topic and the related topic 'MedlinePlus Genetics' from the page. This reduces RA-related references and genetics context shown on the page.SummaryDifference0.1%

- Check31 days agoChange DetectedLocations were updated to add many new sites across the US and other regions, and several existing sites were removed. This changes the list of sites shown for the BALANCE-EXTEND study.SummaryDifference2%

- Check38 days agoChange DetectedThe 'Rheumatoid arthritis' topic and the 'MedlinePlus Genetics' related topic were removed. This reduces the page's core contextual content and linked resources.SummaryDifference0.1%

Stay in the know with updates to Upadacitinib in RA: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib in RA: Safety & Efficacy Clinical Trial page.